1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone and Elevated Cholesterol

1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone has been researched along with Elevated Cholesterol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burnett, DA; Burrier, RE; Caplen, MA; Clader, JW; Davis, HR	1
Bal, CS; Goel, RK; Kulkarni, SK; Mahajan, MP; Thind, JS	1
Bowkow, G; Burnett, DA; Burrier, RE; Caplen, MA; Clemmons, AL; Compton, DS; Davis, HR; Hoos, LM; McGregor, DG; Salisbury, BG	1
Bays, H; Cuffie-Jackson, C; Davidson, MH; Dujovne, CA; Goldberg, AC; Hunninghake, DB; Jones, P; Knopp, R; Lipka, LJ; Stein, EA	1
Compton, DS; Davis, HR; van Heek, M	1

Trials

1 trial(s) available for 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone and Elevated Cholesterol

Article	Year
Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study. Journal of clinical pharmacology, 2001, Volume: 41, Issue:1 Topics: Anticholesteremic Agents; Apolipoprotein A-I; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Placebos; Triglycerides	2001

Article

Year

Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.

Journal of clinical pharmacology, 2001, Volume: 41, Issue:1

Topics: Anticholesteremic Agents; Apolipoprotein A-I; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Placebos; Triglycerides

2001

Other Studies

4 other study(ies) available for 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone and Elevated Cholesterol

Article	Year
2-Azetidinones as inhibitors of cholesterol absorption. Journal of medicinal chemistry, 1994, Jun-10, Volume: 37, Issue:12 Topics: Absorption; Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Cricetinae; Disease Models, Animal; Hypercholesterolemia; Male; Mesocricetus; Microsomes; Rats; Sterol O-Acyltransferase; Structure-Activity Relationship	1994
Hypocholesterolemic activity of some novel azetidin-2-ones in diet and diabetes induced hypercholesterolemia in rats. Die Pharmazie, 2005, Volume: 60, Issue:5 Topics: Animals; Anticholesteremic Agents; Azetidines; Diabetes Mellitus, Experimental; Diet; Female; Hypercholesterolemia; Liver; Male; Rats; Rats, Wistar; Sterol O-Acyltransferase; Structure-Activity Relationship	2005
Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis, 1995, Volume: 115, Issue:1 Topics: Administration, Oral; Animals; Anticholesteremic Agents; Apolipoproteins; Azetidines; Cell Line; Cholesterol; Cholesterol, Dietary; Cricetinae; Feces; Humans; Hypercholesterolemia; Intestinal Absorption; Lipoproteins; Liver; Macaca mulatta; Male; Mesocricetus; Rats; Sterols	1995
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. European journal of pharmacology, 2001, Mar-09, Volume: 415, Issue:1 Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Ezetimibe; Female; Hypercholesterolemia; Macaca fascicularis; Macaca mulatta; Male; Time Factors; Triglycerides	2001